Blue Trust Inc. Raises Stock Holdings in DaVita Inc. (NYSE:DVA)

Blue Trust Inc. boosted its holdings in shares of DaVita Inc. (NYSE:DVA) by 39.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 461 shares of the company’s stock after purchasing an additional 131 shares during the quarter. Blue Trust Inc.’s holdings in DaVita were worth $76,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in DVA. Transcendent Capital Group LLC acquired a new stake in DaVita in the third quarter valued at $25,000. Quarry LP bought a new stake in shares of DaVita in the 3rd quarter worth about $60,000. Versant Capital Management Inc raised its stake in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares in the last quarter. ORG Wealth Partners LLC bought a new position in shares of DaVita during the third quarter worth about $97,000. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its stake in DaVita by 295.9% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 669 shares of the company’s stock worth $110,000 after purchasing an additional 500 shares in the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Barclays upped their price objective on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $161.80.

DaVita Trading Up 0.8 %

NYSE DVA opened at $173.45 on Friday. The firm has a market capitalization of $14.22 billion, a PE ratio of 18.71, a price-to-earnings-growth ratio of 0.86 and a beta of 0.94. DaVita Inc. has a one year low of $108.76 and a one year high of $179.60. The company has a 50-day simple moving average of $160.59 and a 200-day simple moving average of $156.34. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.